Trinity Biotech reported $-9.6M in EBITDA for its fiscal quarter ending in December of 2024.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Bayer EUR 2.14B 2.31B Jun/2026
Bio-Rad Laboratories USD -636.6M 1.62B Mar/2026
EDAP TMS EUR -6.47M 1.54M Mar/2026
J&J USD 8.27B 1.08B Mar/2026
Mesa Laboratories USD 9.58M 1.47M Sep/2024
OraSure Technologies USD -17.7M 4.06M Dec/2025
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Roche Holding CHF 13.43B 744M Jun/2026
Siemens EUR 3.56B 80M Mar/2026
Thermo Fisher Scientific USD 3.55B 845M Jun/2026
Tosoh JPY 39.13B 286M Dec/2024
Trinity Biotech USD -9.6M 7.64M Dec/2024
Veracyte USD 43.96M 1.16M Jun/2026